Kinga Labunets

Ms. Kinga Labunets


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
WCWeronika Ciećko
Weronika Ciećko
KLKinga Labunets
Kinga Labunets
MWMałgorzata Wojnarowska
Małgorzata Wojnarowska
DBDominika Bosek
Dominika Bosek
JSJustyna Skwierawska
Justyna Skwierawska
EBEwa Bandurska
Ewa Bandurska
Background: The COVID-19 pandemic has significantly contributed to accelerating the development of telemedicine and eHealth. The main aim of this study was to assess the attitudes of patients towards remote care implemented in general practice (GP) during the pandemic. Methods: The study was a pilot study conducted in March–April 2021, considering technical aspects of using teleconsultations, and evaluating the difficulties, advantages and disadvantages for patients. When assessing opinions, a simple Likert scale was used, where a value of 1 meant the worst possible assessment or strong disagreement and the upper value the best or full agreement of the respondent. Results: The study covered 408 respondents. Their biggest organizational challenge reaching GPs by telephone, regardless of the patients’ home location (p = 0.23698). Obtaining e-documents was not problematic but was rated as worse by men (p = 0.048295). Respondents rated the overall effectiveness of teleconsultations more highly if they could speak directly with a doctor (p = 0.0005). There were no differences in willingness to recommend teleconsultations based on gender (p = 0.2432), place of residence (p = 0.7878), age (p = 0.290355) or education (p = 0.9109), but people assessing the overall effectiveness of telemedicine more highly were more willing to recommend it (p = 0.000). Conclusions: Respondents assess teleconsultations in a differentiated way, noticing both positive and negative features of the remote form of providing health services.

1 July 2025 in Child Neurology
Verified
Journal Article
Open access
PDF file
KŚKarolina Śledzińska
Karolina Śledzińska
JWJolanta Wierzba
Jolanta Wierzba
KLKinga Labunets
Kinga Labunets
Rare diseases (RD) occur with an incidence of less than 1:2000, mostly manifest in childhood and may cause diagnostic difficulties with its chronic and severe course. As many as 80% of rare diseases are genetically determined. People with rare diseases constitute a special group of patients — there is no single universal method of treatment, and symptoms usually require specialist and comprehensive diagnostics, most of them are diagnosed with varying degrees of developmental delay, including intellectual disability or autism spectrum disorders. Rare diseases patients require difficult, often expensive therapies and constant rehabilitation. Providing appropriate multi-specialist and individualized care for people with rare diseases is a challenge for the healthcare system — currently, models of coordinated treatment are being developed. Keywords: rare diseases multispecialty coordinated care